PROCEPT BioRobotics Corporation Shareholders' Equity
PROCEPT BioRobotics Corporation (PRCT) had Shareholders' Equity of $340.07 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $340.07M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $347.67M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $365.87M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $380.28M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $340.07M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $347.67M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $365.87M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $380.28M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $385.80M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $389.16M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $402.22M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $241.22M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $251.78M 10-Q · filed 2025-11-05 |
| 2024-03-31 | $264.05M 10-Q · filed 2025-11-05 |
| 2023-12-31 | $280.75M 10-K · filed 2026-02-26 |
| 2023-09-30 | $299.36M 10-Q · filed 2024-10-28 |
| 2023-06-30 | $155.90M 10-Q · filed 2024-10-28 |
| 2023-03-31 | $173.13M 10-Q · filed 2024-10-28 |
| 2022-12-31 | $197.07M 10-K · filed 2026-02-26 |
| 2022-09-30 | $220.76M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $239.19M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $252.75M 10-Q · filed 2023-11-02 |
| 2021-12-31 | $267.09M 10-K · filed 2025-02-27 |
| 2021-09-30 | $283.31M 10-Q · filed 2022-11-04 |
| 2021-06-30 | -$206.31M 10-Q · filed 2022-11-04 |
| 2021-03-31 | -$193.86M 10-Q · filed 2022-11-04 |
| 2020-12-31 | -$182.89M 10-K · filed 2024-02-28 |
| 2020-09-30 | -$168.43M 10-Q · filed 2021-11-05 |
| 2020-06-30 | -$166.54M 10-Q · filed 2021-11-05 |
| 2020-03-31 | -$155.38M 10-Q · filed 2021-11-05 |
| 2019-12-31 | -$143.84M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |